Objectives Some practitioners are adopting proactive topical corticosteroid (TCS) therapy for vulval lichen sclerosus (VLS). We sought to understand patient attitudes toward proactive TCS therapy for VLS in a context in which proactive therapy is adopted. Methods Four online focus group discussions with 12 participants. Data analysis was informed by social constructionist grounded theory. Results All participants had accepted a proactive regimen. Three themes were developed from the analysis: “Coming to accept proactive therapy,” “Motivators to maintaining a proactive regimen,” and “The importance of a routine that fits me.” Within each theme are subthemes illustrating different dimensions of the theme. Conclusions Accepting proactive TCS therapy for VLS requires incorporating regular TCS use into a patient's identity, unlearning previous understandings regarding the safety of long-term TCS use, and adopting a regimen that fits within patients' lives and minimizes the loss of autonomy.
No takes yet. Share an insight, caveat, or question.
Rees et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: